NSPR logo

InspireMD (NSPR) Cash From Operations

Annual CFO

-$16.38 M
-$834.00 K-5.37%

December 31, 2023


Summary


Performance

NSPR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNSPRcash flowmetrics:

Quarterly CFO

-$5.70 M
-$1.35 M-30.91%

September 30, 2024


Summary


Performance

NSPR Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNSPRcash flowmetrics:

TTM CFO

-$19.30 M
-$1.66 M-9.39%

September 30, 2024


Summary


Performance

NSPR TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNSPRcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NSPR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.4%-41.0%-25.3%
3 y3 years-80.3%-37.7%-54.3%
5 y5 years-115.3%-284.4%-165.6%

NSPR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.0%at low-96.5%at low-46.1%at low
5 y5-year-80.3%at low-284.4%at low-165.6%at low
alltimeall time<-9999.0%+15.4%<-9999.0%+3.7%<-9999.0%+4.8%

InspireMD Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.70 M(+30.9%)
-$19.30 M(+9.4%)
Jun 2024
-
-$4.35 M(-14.0%)
-$17.64 M(+6.2%)
Mar 2024
-
-$5.06 M(+21.2%)
-$16.61 M(+1.4%)
Dec 2023
-$16.38 M(+5.4%)
-$4.18 M(+3.3%)
-$16.38 M(+6.4%)
Sep 2023
-
-$4.04 M(+21.6%)
-$15.39 M(-6.4%)
Jun 2023
-
-$3.33 M(-31.2%)
-$16.45 M(+1.3%)
Mar 2023
-
-$4.83 M(+51.2%)
-$16.24 M(+4.5%)
Dec 2022
-$15.54 M(+17.7%)
-$3.19 M(-37.4%)
-$15.54 M(+1.9%)
Sep 2022
-
-$5.10 M(+64.2%)
-$15.25 M(+6.7%)
Jun 2022
-
-$3.11 M(-24.8%)
-$14.28 M(+4.2%)
Mar 2022
-
-$4.13 M(+42.5%)
-$13.70 M(+3.7%)
Dec 2021
-$13.21 M(+45.5%)
-$2.90 M(-29.9%)
-$13.21 M(+5.6%)
Sep 2021
-
-$4.14 M(+63.8%)
-$12.51 M(+9.6%)
Jun 2021
-
-$2.53 M(-30.6%)
-$11.41 M(+10.1%)
Mar 2021
-
-$3.64 M(+65.5%)
-$10.37 M(+14.2%)
Dec 2020
-$9.08 M(-7.4%)
-$2.20 M(-27.7%)
-$9.08 M(+7.5%)
Sep 2020
-
-$3.04 M(+105.3%)
-$8.45 M(+16.3%)
Jun 2020
-
-$1.48 M(-37.0%)
-$7.26 M(-16.3%)
Mar 2020
-
-$2.35 M(+50.1%)
-$8.68 M(-11.5%)
Dec 2019
-$9.81 M(+29.0%)
-$1.57 M(-15.7%)
-$9.81 M(-2.3%)
Sep 2019
-
-$1.86 M(-35.8%)
-$10.04 M(+0.3%)
Jun 2019
-
-$2.90 M(-16.9%)
-$10.01 M(+7.6%)
Mar 2019
-
-$3.48 M(+93.3%)
-$9.31 M(+22.4%)
Dec 2018
-$7.61 M(-6.5%)
-$1.80 M(-1.4%)
-$7.61 M(+0.4%)
Sep 2018
-
-$1.83 M(-16.6%)
-$7.58 M(-2.3%)
Jun 2018
-
-$2.19 M(+23.3%)
-$7.76 M(+8.4%)
Mar 2018
-
-$1.78 M(+0.3%)
-$7.15 M(-12.0%)
Dec 2017
-$8.13 M
-$1.77 M(-11.6%)
-$8.13 M(-1.3%)
Sep 2017
-
-$2.01 M(+26.3%)
-$8.24 M(-10.3%)
Jun 2017
-
-$1.59 M(-42.3%)
-$9.18 M(+9.5%)
DateAnnualQuarterlyTTM
Mar 2017
-
-$2.76 M(+46.6%)
-$8.39 M(+11.9%)
Dec 2016
-$7.50 M(-35.4%)
-$1.88 M(-36.3%)
-$7.50 M(-4.3%)
Sep 2016
-
-$2.96 M(+272.2%)
-$7.83 M(+8.6%)
Jun 2016
-
-$794.00 K(-57.4%)
-$7.21 M(-18.4%)
Mar 2016
-
-$1.86 M(-15.9%)
-$8.84 M(-23.8%)
Dec 2015
-$11.60 M(-40.1%)
-$2.22 M(-5.0%)
-$11.60 M(-19.9%)
Sep 2015
-
-$2.33 M(-3.7%)
-$14.47 M(-19.9%)
Jun 2015
-
-$2.42 M(-47.6%)
-$18.05 M(-11.0%)
Mar 2015
-
-$4.62 M(-9.2%)
-$20.27 M(+4.7%)
Dec 2014
-$19.36 M(+184.8%)
-$5.09 M(-14.0%)
-$19.36 M(+35.7%)
Sep 2014
-
-$5.92 M(+27.4%)
-$14.27 M(+22.8%)
Jun 2014
-
-$4.64 M(+25.2%)
-$11.63 M(+34.2%)
Mar 2014
-
-$3.71 M(+13.4%)
-$8.66 M(-22.7%)
Dec 2013
-$6.80 M(-34.0%)
-
-
Sep 2013
-
-$3.27 M(+94.3%)
-$11.22 M(+8.9%)
Jun 2013
-
-$1.68 M(-40.2%)
-$10.30 M(+19.5%)
Jun 2013
-$10.30 M(+136.1%)
-
-
Mar 2013
-
-$2.82 M(-18.2%)
-$8.62 M(+16.8%)
Dec 2012
-
-$3.44 M(+46.1%)
-$7.38 M(+21.2%)
Sep 2012
-
-$2.36 M(+49.2%)
-$6.09 M(-15.7%)
Jun 2012
-$4.36 M(-27.3%)
-
-
Mar 2012
-
-$1.58 M(-26.6%)
-$7.22 M(+20.3%)
Dec 2011
-$6.00 M(>+9900.0%)
-$2.15 M(+4.2%)
-$6.00 M(+55.8%)
Sep 2011
-
-$2.06 M(+44.9%)
-$3.85 M(+115.0%)
Jun 2011
-
-$1.43 M(+294.7%)
-$1.79 M(+388.4%)
Mar 2011
-
-$361.00 K(>+9900.0%)
-$366.90 K(+6118.6%)
Dec 2010
-
-$900.00(-82.0%)
-$5900.00(+18.0%)
Sep 2010
-
-$5000.00
-$5000.00
Jun 2010
-$19.00 K(+2275.0%)
-
-
Jun 2009
-$800.00
-
-

FAQ

  • What is InspireMD annual cash flow from operations?
  • What is the all time high annual CFO for InspireMD?
  • What is InspireMD annual CFO year-on-year change?
  • What is InspireMD quarterly cash flow from operations?
  • What is the all time high quarterly CFO for InspireMD?
  • What is InspireMD quarterly CFO year-on-year change?
  • What is InspireMD TTM cash flow from operations?
  • What is the all time high TTM CFO for InspireMD?
  • What is InspireMD TTM CFO year-on-year change?

What is InspireMD annual cash flow from operations?

The current annual CFO of NSPR is -$16.38 M

What is the all time high annual CFO for InspireMD?

InspireMD all-time high annual cash flow from operations is -$800.00

What is InspireMD annual CFO year-on-year change?

Over the past year, NSPR annual cash flow from operations has changed by -$834.00 K (-5.37%)

What is InspireMD quarterly cash flow from operations?

The current quarterly CFO of NSPR is -$5.70 M

What is the all time high quarterly CFO for InspireMD?

InspireMD all-time high quarterly cash flow from operations is -$900.00

What is InspireMD quarterly CFO year-on-year change?

Over the past year, NSPR quarterly cash flow from operations has changed by -$1.66 M (-40.98%)

What is InspireMD TTM cash flow from operations?

The current TTM CFO of NSPR is -$19.30 M

What is the all time high TTM CFO for InspireMD?

InspireMD all-time high TTM cash flow from operations is -$5000.00

What is InspireMD TTM CFO year-on-year change?

Over the past year, NSPR TTM cash flow from operations has changed by -$3.90 M (-25.34%)